Less than a week after Health Canada removed limits on how much pot it could produce, Gatineau-based Hydropothecary (TSX-V:THCX) says it’s raising $20 million in new financing.
The firm said Tuesday that it had entered into an agreement with its longtime financing partner, Canaccord Genuity Corp., and a syndicate of underwriters to raise the money via a private placement.
Last week, Health Canada approved two new buildings at Hydropothecary’s Gatineau facilities and granted the pot producer a licence renewal to grow and sell as much cannabis as it can store.
OBJ360 (Sponsored)
Ottawa’s Paterson Group offers a million reasons to give
There’s a particular image that David Gilbert, President of Ottawa-based Paterson Group, is delighted to share. It’s a map of the Ottawa area and beyond covered with thousands of dots,
AI notetaking for meetings? It could cost you if you don’t do your legal due diligence
We’ve all been there: You hop on a video call and see that, along with your fellow meeting attendees, AI notetaking software is also there, recording, transcribing, and diligently listening
A Hydropothecary spokesperson said Tuesday that the loosened restrictions signal a major move on the part of Health Canada to fast-track industry expansion ahead of the federal government’s plans to legalize marijuana for recreational use by July 2018.
The move came as Ontario Finance Minister Charles Sousa was quoted as saying that he expects a shortage of marijuana when it’s legalized, echoing previous comments by financial analysts.
Hydropothecary’s stock price was down 9.5 per cent, or 15 cents per share, to $1.43 in late-afternoon trading on the TSX Venture Exchange.
